Predoctoral researcher at the Nanoprobes and Nanoswitches Research Group
Ref: Phd-PG // Deadline: 08/03/2026
Ref: Phd-PG // Deadline: 08/03/2026
Ref: PR-PG // Deadline: 05/03/2026
A study led by the Institute for Bioengineering of Catalonia (IBEC) and the Molecular Biology Institute of Barcelona (IBMB) provides the most detailed picture to date of NrdR — the master regulator of ribonucleotide reductases (RNRs) in bacteria. Researchers obtained the first detailed images of the complete NrdR protein structure and showed how changes in the shape and grouping of this protein affect the way it controls key processes inside the cell. The findings, recently published in International Journal of Biological Macromolecules, increase our understanding of how bacteria regulate the production of the molecular building blocks of DNA, a crucial aspect for both fundamental microbiology and the development of new antimicrobial strategies.
Developing Nanomedicines Using the Zebrafish Embryo Federico Fenaroli , University of Stavanger Our research focuses on the development of nanomedicines to combat bacterial infections and cancer. We investigate the dynamic … Read more
A new study led by the Institute for Bioengineering of Catalonia (IBEC) has unveiled the first biomaterial that is not only waterproof but actually becomes stronger in contact with water. The material is produced by the incorporation of nickel into the structure of chitosan, a chitinous polymer obtained from discarded shrimp shells. The development of this new biomaterial, published in Nature Communications, marks a departure from the plastic-age mindset of making materials that must isolate from their environment to perform well. Instead, it shows how sustainable materials can connect and leverage their environment, using their surrounding water to achieve mechanical performance that surpasses common plastics.
Today, researchers, clinicians and innovation experts gathered at a conference organised by the Institute for Bioengineering of Catalonia (IBEC) as part of Barcelona Health Innovation Week 2026. The conference focused on accelerating the transfer of results towards a more personalised, preventive and sustainable future of medicine. The session emphasised the importance of strengthening interdisciplinary alliances to bring scientific advances to patients sooner, and highlighted the role of the Catalan biomedical ecosystem and the progress made by the Complementary Plan for Biotechnology Applied to Health in Catalonia.
Ref: ST-RJ // Deadline: 02/03/2026
IBEC researcher Amayra Hernández-Vega has been awarded a grant from the Pasqual Maragall Researchers Programme to lead a project focused on studying the earliest stages of Alzheimer’s disease. The study will combine in vitro and human models of familial Alzheimer’s disease to identify age-related factors and potential inhibitors that could slow the early progression of the disease. The project was presented at an informative session on sleep and brain health, which was attended by around 500 people.